Themis Medicare Faces Significant Volatility Amidst Declining Performance Metrics

Themis Medicare, a small-cap player in the Pharmaceuticals and Biotechnology sector, has experienced significant volatility today, hitting a new 52-week low of Rs. 99.9. This marks a notable decline, as the stock has underperformed its sector by 1.86% and has seen a consecutive fall over the past five days, resulting in a total drop of 10.44%. The stock's intraday low reached Rs. 99.9, reflecting a decrease of 5.04% for the day.
In terms of performance metrics, Themis Medicare's one-year performance stands at a staggering -57.74%, contrasting sharply with the Sensex's modest gain of 1.89% during the same period. The company's operating profit has seen a dramatic decline, with a reported annual growth rate of -138.71% over the last five years. Additionally, the latest six-month net sales figure of Rs. 169.28 crore represents a decrease of 23.34%.

Despite these challenges, Themis Medicare maintains a low Debt to EBITDA ratio of 1.16 times, indicating a strong ability to service its debt. However, the stock's overall performance and negative operating profits raise concerns about its market position and long-term viability.